-
Aiforia appoints Swedbank as lead advisor to explore financing options
prnasia
March 16, 2021
Aiforia Technologies Oy has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.
-
Wayra, GE Healthcare launch accelerator programme for digital health start-ups
pharmatimes
March 01, 2021
Wayra and GE Healthcare have launched an accelerator programme across the Europe, the Middle East and Africa (EMEA) region to support digital health start-ups to develop AI applications for healthcare.
-
Regulatory agencies have provided various leverages to adopt digital technologies in business operations
expresspharma
February 24, 2021
As a technology partner, tell us how COVID-19 is causing a metamorphosis in the life sciences industry. Which areas of the pharma value chain will see the most far-reaching changes? What will be the drivers?
-
Windlas Biotech, Mateon Therapeutics partner to launch combined lung therapy and AI telemedicine solution
expresspharma
February 23, 2021
The solution consists of three components: the drug PulmoHeal, an AI lung health assessment tool called ArtiHealthand, a post-marketing survey platform.
-
OSE Immunotherapeutics Expands Collaboration with MAbSilico
americanpharmaceuticalreview
February 05, 2021
OSE Immunotherapeutics announced a new collaboration agreement with MAbSilico, a deep technology TechBio located in Tours, France, to use artificial intelligence (AI)-based software for therapeutic monoclonal antibody drug development.
-
IIT Mandi-led team develops AI app to track home quarantined COVID patients
expresspharma
February 05, 2021
A team led by researchers at the Indian Institute of Technology (IIT) Mandi has developed an artificial intelligence (AI) based biometric application to continuously monitor and accurately detect the identity of a home quarantined COVID-19 patient.
-
o9 Solutions to supply AI-powered IBP platform to Samsung Bioepis
expresspharma
February 02, 2021
o9 Solutions, a AI-powered IBP platform provider has announced that it would supply its next-generation platform to Samsung Bioepis bolstering the management of its biopharmaceutical product manufacturing and supply chain.
-
AI to be most transformative technology for pharma, finds survey
europeanpharmaceuticalreview
February 01, 2021
A new report suggests artificial intelligence (AI) will be the most disruptive technology in the pharmaceutical industry this year and beyond.
-
AI to be most disruptive technology across pharma industry in 2021 and beyond
expresspharma
January 25, 2021
GlobalData analysis shows that while four partnerships were forged between AI vendors and large pharma companies in 2015, they rose to 27 by 2020, an increase of 575 per cent in just six years.
-
CES 2021 Taiwan, Chinaese biotech startup mProbe CADx develops AI health analysis platform
prnasia
January 13, 2021
mProbe Taiwan, China is a subsidiary biotechnology company of mProbe Inc, committed to promoting human health and wellness by transforming the field of precision health and precision medicine.